lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

ODN 2216 Uptake Induced TLR9 Signaling Mediates Phenotypic Changes in CD4+ T Cells

45 Pages Posted: 12 Apr 2019

See all articles by Ravi Kumar Sharma

Ravi Kumar Sharma

Post Graduate Institute of Medical Education & Research (PGIMER)

Jyoti Sharma

Post Graduate Institute of Medical Education & Research (PGIMER)

Rajendra Kumar

Indian Institute of Science Education and Research (IISER)

Ajinkya Pattekar

Drexel University - College of Medicine

Shobha Sehgal

Post Graduate Institute of Medical Education & Research (PGIMER)

Amod Gupta

Post Graduate Institute of Medical Education & Research (PGIMER)

Pooja Jain

Drexel University - College of Medicine

Naresh Sachdeva

Post Graduate Institute of Medical Education & Research (PGIMER) - Department of Endocrinology

More...

Abstract

Background: Oligodeoxynucleotides (ODNs) are established TLR9 ligands; however, their functional responses in CD4+ T cells are believed to be independent of TLR9 and MyD88.

Methods: We studied ligand-receptor interactions for ODN 2216 and TLR9 in human CD4+ T cells using confocal microscopy and flow cytometry. We assessed the consequences of this interaction in terms of TLR9 signaling and its effects on cell proliferation and cytokine expression using real time RT-PCR and flow cytometry.

Findings: We demonstrated that endocytosed ODN 2216 physically interacts with intracellular TLR9 inside lysosomes in CD4+ T cells. The uptake of ODN 2216, controlled by TLR9 signaling molecules, resulted in an increase in the expression of TLR9 signaling molecules. Further, we observed that downstream signaling molecules controlled the expression of TLR9 in CD4+ T cells in a feedback dependent manner. Next, the uptake of ODN 2216 resulted in TLR9 signaling dependent but MyD88 independent increase in expression of TGF-β. Finally, ODN 2216 treated CD4+ T cells showed an anti-inflammatory phenotype that was quite similar to Th3 type of regulatory T cells. These Th3 like cells were able to suppress the proliferation of untreated CD4+ T cells.

Interpretation: Collectively, our results demonstrate a direct and interdependent relationship between ODN 2216 uptake and TLR9 signaling in CD4+ T cells. Our findings thus, pave the way for future research to explore direct modulation of adaptive immune cells, using innate immune ligands, to subvert exaggerated inflammatory responses.

Funding Statement: Centre of Excellence, Advance Eye Centre, PGIMER funded by Department of Biotechnology (DBT), Government of India, New Delhi for support (Grant No. BT/01/CEIB/11/02) (awarded to AG and NS) and Indian Council of Medical Research for providing fellowship to RS (3/1/3/JRF-2012/HRD-87). This study was supported in part by the National Institutes of Health/Fogarty International Centre training grant D43 TW009588 (awarded to SL), and the 1R01NS097147 grant (awarded to PJ).

Declaration of Interests: Authors declare no conflict of interest.

Ethics Approval Statement: The Institutional ethics committee duly approved the study (No’s PGI/IEC/2011/532- 533/24/11/11 and NK/1385/PhD/2484/07/09/17). All subjects gave written informed consent in accordance with the Declaration of Helsinki

Keywords: TLR9, CD4+ T cells, Oligodeoxynucleotides, effector T cells, T cell proliferation, immune suppression

Suggested Citation

Sharma, Ravi Kumar and Sharma, Jyoti and Kumar, Rajendra and Pattekar, Ajinkya and Sehgal, Shobha and Gupta, Amod and Jain, Pooja and Sachdeva, Naresh, ODN 2216 Uptake Induced TLR9 Signaling Mediates Phenotypic Changes in CD4+ T Cells (April 10, 2019). Available at SSRN: https://ssrn.com/abstract=3369754 or http://dx.doi.org/10.2139/ssrn.3369754

Ravi Kumar Sharma

Post Graduate Institute of Medical Education & Research (PGIMER)

Department of Community Medicine and Schoo
PGIMER, Sec. 12
Chandigarh
India

Jyoti Sharma

Post Graduate Institute of Medical Education & Research (PGIMER)

Department of Community Medicine and Schoo
PGIMER, Sec. 12
Chandigarh
India

Rajendra Kumar

Indian Institute of Science Education and Research (IISER)

India

Ajinkya Pattekar

Drexel University - College of Medicine

United States

Shobha Sehgal

Post Graduate Institute of Medical Education & Research (PGIMER)

Department of Community Medicine and Schoo
PGIMER, Sec. 12
Chandigarh
India

Amod Gupta

Post Graduate Institute of Medical Education & Research (PGIMER)

Department of Community Medicine and Schoo
PGIMER, Sec. 12
Chandigarh
India

Pooja Jain

Drexel University - College of Medicine

United States

Naresh Sachdeva (Contact Author)

Post Graduate Institute of Medical Education & Research (PGIMER) - Department of Endocrinology ( email )

Chandigarh
India

Click here to go to TheLancet.com

Paper statistics

Abstract Views
206
Downloads
13